These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 12869338)

  • 1. Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey.
    Healey A; Knapp M; Marsden J; Gossop M; Stewart D
    J Health Serv Res Policy; 2003 Jul; 8(3):134-41. PubMed ID: 12869338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrested on heroin: a national opportunity.
    Boutwell AE; Nijhawan A; Zaller N; Rich JD
    J Opioid Manag; 2007; 3(6):328-32. PubMed ID: 18290584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in criminal convictions after addiction treatment: 5-year follow-up.
    Gossop M; Trakada K; Stewart D; Witton J
    Drug Alcohol Depend; 2005 Sep; 79(3):295-302. PubMed ID: 16102373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials.
    Dijkgraaf MG; van der Zanden BP; de Borgie CA; Blanken P; van Ree JM; van den Brink W
    BMJ; 2005 Jun; 330(7503):1297. PubMed ID: 15933353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of an 18-month, NHS-based, treatment exposure for heroin dependence: results from the London Area Treat 2000 Study.
    Schifano F; Martinotti G; Cunniff A; Reissner V; Scherbaum N; Ghodse H
    Am J Addict; 2012; 21(3):268-73. PubMed ID: 22494230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia.
    Afriandi I; Siregar AY; Meheus F; Hidayat T; van der Ven A; van Crevel R; Baltussen R
    Health Policy; 2010 Apr; 95(1):69-73. PubMed ID: 20004491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results.
    Gossop M; Marsden J; Stewart D; Kidd T
    Addiction; 2003 Mar; 98(3):291-303. PubMed ID: 12603229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of first eight methadone maintenance treatment clinics in China.
    Pang L; Hao Y; Mi G; Wang C; Luo W; Rou K; Li J; Wu Z
    AIDS; 2007 Dec; 21 Suppl 8():S103-7. PubMed ID: 18172377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam.
    Vuong T; Shanahan M; Nguyen N; Le G; Ali R; Pham K; Vuong TTA; Dinh T; Ritter A
    Drug Alcohol Depend; 2016 Nov; 168():147-155. PubMed ID: 27664552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The National Treatment Outcomes Research Study (NTORS) and its influence on addiction treatment policy in the United Kingdom.
    Gossop M
    Addiction; 2015 Jul; 110 Suppl 2():50-3. PubMed ID: 26042569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs and consequences of three policy options for reducing heroin dependency.
    Moore TJ; Ritter A; Caulkins JP
    Drug Alcohol Rev; 2007 Jul; 26(4):369-78. PubMed ID: 17564872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic costs of heroin addiction in the United States.
    Mark TL; Woody GE; Juday T; Kleber HD
    Drug Alcohol Depend; 2001 Jan; 61(2):195-206. PubMed ID: 11137285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.
    Langham S; Wright A; Kenworthy J; Grieve R; Dunlop WCN
    Value Health; 2018 Apr; 21(4):407-415. PubMed ID: 29680097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study.
    Uyei J; Fiellin DA; Buchelli M; Rodriguez-Santana R; Braithwaite RS
    Lancet Public Health; 2017 Mar; 2(3):e133-e140. PubMed ID: 29253386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.